A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/22/2006	EP1420778B1 Use of mek inhibitors for treating virus induced hemorrhagic shock or fever
11/22/2006	EP1407261A4 In vivo bioreactors
11/22/2006	EP1401413B1 Use of tyrosine kinase inhibitions for treating allergic diseases
11/22/2006	EP1399156B1 Alkylidene pirazolidinedione derivatives and their use for treating diabetes and obesity
11/22/2006	EP1392287B1 Use of azetidinone substituted derivatives in the treatment of alzheimer's disease
11/22/2006	EP1390360B1 Crystalline form of omeprazole
11/22/2006	EP1368014B1 Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria
11/22/2006	EP1361899B1 Silicon implants comprising a radionucleotide for use in brachytherapy
11/22/2006	EP1360186B1 Carboline derivatives
11/22/2006	EP1355540B1 Food supplement with a slimming effect
11/22/2006	EP1351933B1 Il-8 receptor antagonists
11/22/2006	EP1343765B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
11/22/2006	EP1342472B1 Analgesic and anti-inflammatory patches for external use containing 4-biphenylylacetic acid
11/22/2006	EP1339725B1 Dna methyl transferase inhibitors
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1315482B1 Water-dispersible encapsulated sterols
11/22/2006	EP1312364B1 Gatifloxacin as cytokine production inhibitor
11/22/2006	EP1311272B1 Novel methods using cholinesterase inhibitors
11/22/2006	EP1301487B1 Viral polymerase inhibitors
11/22/2006	EP1301475B1 Aryl sulfonamides as serotonin antagonist for the treatment of obesity
11/22/2006	EP1299081B1 Use of oligosaccharides to stimulate beta-endorphin production
11/22/2006	EP1298132B1 Hydropyridine derivative acid addition salts
11/22/2006	EP1280495B1 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same
11/22/2006	EP1277752B1 Process for producing optically active sulfoxide derivative
11/22/2006	EP1268435B1 4,5-dihydro-1h-pyrazole derivatives having cb 1-antagonistic activity
11/22/2006	EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006	EP1244651B1 Diamidine compounds as dna minor groove binders
11/22/2006	EP1244401B1 Drug delivery of phase changing formulation
11/22/2006	EP1238970B1 Cycloamine ccr5 receptor antagonists
11/22/2006	EP1221934B1 Method for producing antimicrobial perfuming compositions
11/22/2006	EP1214098B1 Capsid-modified recombinant adenovirus and methods of use
11/22/2006	EP1163522B1 Method for detecting msrv-1 induced superantigen activity in a biological sample
11/22/2006	EP1120114B1 Compositions and methods for treating conditions responsive to estrogen
11/22/2006	EP1096924B1 Inhibitors of proteasomal activity for stimulating hair growth
11/22/2006	EP1080070B1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
11/22/2006	EP1071774B1 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof
11/22/2006	EP1066247B1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
11/22/2006	EP1054674B1 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
11/22/2006	EP1051395B1 N-hydroxyformamide derivatives
11/22/2006	EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006	EP1000158B1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
11/22/2006	EP0970104B1 Steroid sulfamates, method for the production and use thereof
11/22/2006	EP0952819B1 Biologically active composition
11/22/2006	EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase
11/22/2006	EP0935415B1 In vitro methods for delivering nucleic acids into a cell
11/22/2006	EP0890105B1 Methods related to Alzheimer's disease for diagnosis, manufacture of medicaments and screening of substances and beta-amyloid related peptides
11/22/2006	EP0871435B1 Sustained release formulation containing three different types of polymers
11/22/2006	EP0825996B1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/22/2006	EP0780122B1 Depressant of functions developed by molecule
11/22/2006	EP0512090B2 Treatment of inflammation
11/22/2006	CN1867664A Production of tacrolimus (fk-506) using new streptomyces species
11/22/2006	CN1867579A Novel peptidomimetic NS3-serine protease inhibitors of hepatitis c virus
11/22/2006	CN1867578A The conjugates of a hydrophilic polymer-buxus's extracts and the pharmaceutical compositions of thereof
11/22/2006	CN1867577A Estratriene derivatives
11/22/2006	CN1867573A Process for the preparation of trans- or cis-diammoniumdichlorodihydroxyplatinum(iv) salts and derivatives and their use for the preparation of pharmaceutical active agents
11/22/2006	CN1867572A Proteasome inhibitors and methods of using the same
11/22/2006	CN1867570A Isothiazoloquinolones and related compounds as anti-infective agents
11/22/2006	CN1867569A 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents
11/22/2006	CN1867568A Diazabicyclononene derivatives and their use as renin inhibitors
11/22/2006	CN1867567A 1-'(e)-2-(phenyl)ethenyl-4-(arylalkoxy)-oxazole or -thiazole compounds as her-2 tyrosine kinases inhibitors and their use in the treatment of cancer
11/22/2006	CN1867566A Aminopyrones and their use as ATM inhibitors
11/22/2006	CN1867565A Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes
11/22/2006	CN1867564A Process for preparing amino crotonyl compounds
11/22/2006	CN1867563A Novel imidazole derivatives and their use as pharmaceutical agents
11/22/2006	CN1867562A Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
11/22/2006	CN1867561A Novel triarylimidazoles
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1867559A Glutamine fructose-6-phosphate amidotransferase (GFAT) inhibitors
11/22/2006	CN1867557A Substitute thiophenes and uses therof
11/22/2006	CN1867555A Rearranged pentanols, a process for their production and their use as anti-inflammatory agents
11/22/2006	CN1867554A Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors
11/22/2006	CN1867552A Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change
11/22/2006	CN1867551A Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists
11/22/2006	CN1867550A Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders
11/22/2006	CN1867549A Cyclopropyl derivatives as NK3 receptor antagonists
11/22/2006	CN1867548A Preparation of 3-azabicyclo [3.1.0] hexane derivatives
11/22/2006	CN1867547A Compounds having crth2 antagonist activity
11/22/2006	CN1867546A Novel compound and its uses in medicine, its preparation method and its pharmaceutical composition comprising same
11/22/2006	CN1867543A Polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
11/22/2006	CN1867363A Mechanism-based targeted pancreatic beta cell imaging and therapy
11/22/2006	CN1867362A Cancer gene therapeutic drug
11/22/2006	CN1867361A Cancer gene therapeutic drug
11/22/2006	CN1867359A Methylphenidate solution and associated methods of administration and produciton
11/22/2006	CN1867358A Combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression
11/22/2006	CN1867350A Recombinant lubricin molecules and uses thereof
11/22/2006	CN1867346A Plant part of opuntia and/or its extract in treatment of depression
11/22/2006	CN1867343A Therapeutic formulations
11/22/2006	CN1867342A A pharmaceutical composition used for treating recurrent spontaneous abortion and method thereof
11/22/2006	CN1867341A Compositions for controlling parasites comprising a combination of abamectin and milbemycin
11/22/2006	CN1867340A Topical use of halosalicylic acid derivatives
11/22/2006	CN1867339A Novel use of cannabinoid receptor agonist
11/22/2006	CN1867338A Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
11/22/2006	CN1867337A Methods for intradermal delivery of therapeutics agents
11/22/2006	CN1867336A 1-aryl-4-substituted piperazines derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
11/22/2006	CN1867335A Novel use of quinolone antibiotics
11/22/2006	CN1867334A Quinolinone derivatives as inhibitors of c-fms kinase
11/22/2006	CN1867333A Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
11/22/2006	CN1867332A Combination treatment of obesity involving selective cb1-antagonists and lipase inhibitors
11/22/2006	CN1867331A Thalidomide analogs as TNF-alpha modulators
11/22/2006	CN1867330A N-substituted azacycles

1 ... 3999 4000 4001 4002 4003 4004 4005 4006 4007 4008 4009 4010 4011 4012 4013 4014 4015 4016 4017 4018 4019 ... 7860